Amy Y Huang

8PUBLICATIONS
78CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 25, 2026
Genomic, Clinical, and Spatial Predictors of Durable Response to BRAF/MEK Inhibition in BRAF-Mutant Melanoma.

|Feb 12, 2026
Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 Immunotherapy.

Matthew P Zimmerman, Amy Y Huang, Emily K Cox

|Sep 01, 2025
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma.

Jiekun Yang, Cassia Wang, Doris Fu

|Nov 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma.

Giuseppe Tarantino, Cora A Ricker, Annette Wang

|Nov 18, 2024
Stratified analysis identifies HIF-2α as a therapeutic target for highly immune-infiltrated melanomas.

Amy Y Huang, Kelly P Burke, Ryan Porter

|Sep 17, 2024
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control.

Sarah A Weiss, Amy Y Huang, Megan E Fung

Pageof 2

Frequent Collaborators

4 joint publications

Arlene H Sharpe

3 joint publications

David Liu

2 joint publications

Brian C Miller

2 joint publications

John G Doench